USQ has this week welcomed a new Deputy Vice-Chancellor (Research and Innovation) who brings with him a wealth of experience in enhancing research performance.
Tell a friend!
Professor Mark Harvey has a diverse background including research, technology transfer and venture capital, and has played major roles in securing research funding from industry and grant agencies, and commercialisation of university intellectual property assets.
He will lead a team of university staff and researchers in enhancing the research performance of the university.
'I will be working closely with researchers to maximise funding from granting bodies and industry at large,' Professor Harvey said.
'Our focus will also be to effectively transfer the knowledge and research outcomes to the community, so it will benefit those who funded the research in the first place.'
Professor Harvey will be based at USQ’s Springfield campus on Brisbane’s south-western outskirts reflecting USQ’s strategic plan to pursue world-class research, innovation and practice.
'Being based close to Brisbane will create opportunities for communication between the university, business, industry organisations and government and allow us to forge strong and mutually beneficial partnerships.'
Professor Harvey said his first months will be spent meeting as many researchers as possible to build a vision for research at the university.
Before accepting this appointment, Professor Harvey was a partner with CM Capital Investments, one of Australia’s leading venture capital companies with over $250 million under management and investments in companies in the fields of life sciences, telecommunications, information technology and renewable energy.
'My role as a venture capitalist was to identify and invest in early-stage companies and organisations involved in innovative research,' Professor Harvey said.
'As the venture capital fund owns equity in the companies, we took an active role in building teams and guiding these ventures, assisting them to obtain research and development funding.'
Prior to CM Capital Professor Harvey was Chief Executive Officer of a specialised investment and development company, and in the late 1990s he was a Senior Lecturer at the Queensland University of Technology with National Health and Medical Research Council (NHMRC) funded research programs.
He then moved into technology transfer and commercialisation, spending five years at UniQuest, the commercialisation company of the University of Queensland.
Mark has established more than a dozen university start-up companies across a wide variety of disciplines including agriculture, education, human health and social sciences.
During the past 12 years he has been instrumental in securing research funding totalling tens of millions of dollars and has been on the board of directors of ASX and NASDAQ listed companies.
He has also been a member of the Investment Committee of two University seed funds.